Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72632 record(s)

Req # A-2019-001553

Final version or latest draft and emails associated with Order Paper question Q-2522, put on notice on June 7, 2019. Time frame is June 7, 2019 to September 12, 2019.

Organization: Health Canada

66 page(s)
June 2020

Req # A-2019-001794

All records on a product presently considered for access by Health Canada's Special Access Program (SAP). The product is KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE INJECTION. From January 01, 2015 to December 31, 2019.

Organization: Health Canada

6 page(s)
June 2020

Req # A-2019-001860

Copies of all external submissions which went into crafting the 2013 Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Data by Sex.

Organization: Health Canada

80 page(s)
June 2020

Req # A-2020-000174

Adverse Reaction Report (AER). Report number: E2B_02987919.

Organization: Health Canada

12 page(s)
June 2020

Req # A-2020-000208

All records describing the isolation of a SARS-COV-2 virus, directly from a sample taken from a diseased patient, where the patient sample was not first combined with any other source of genetic material (i.e. monkey kidney cells aka vero cells;…

Organization: Health Canada

0 page(s)
June 2020

Req # A-2020-000273

Any Abbreviated New Drug Submission (ANDS) submissions that are still under review that were initially filed between June 1, 2017 and July 15, 2017. How many of these submissions are still under review?

Organization: Health Canada

0 page(s)
June 2020

Req # A-2020-000274

Any Abbreviated New Drug Submission (ANDS) submissions (i.e., the sponsor, the reference product and the proposed product) that are still under review that were initially filed between June 1, 2017 and July 15, 2017.

Organization: Health Canada

0 page(s)
June 2020

Req # A-2020-000277

All Health Canada documents produced from November 1, 2019 to May 25, 2020, related to Canada's need for medical personal protective equipment, testing equipment and/or ventilators for intensive care.

Organization: Health Canada

0 page(s)
June 2020

Req # A-2020-000279

All emails received or sent between November 1, 2019 and April 20, 2020 by a person in the position of Deputy Minister, and those in the office of the Minister of Health, regarding stocks of personal protective equipment and ventilators in the…

Organization: Health Canada

0 page(s)
June 2020

Req # A-2020-000281

All emails received or sent by deputy ministers of health, or by any person acting specifically on their behalf, addressed to the office of the Minister of Health, regarding directives for air transportation related to the coronavirus outbreak from…

Organization: Health Canada

0 page(s)
June 2020
Date modified: